AngioDynamics, Inc. Share Price & Technical Analysis

ANGO · $11.92 (-0.33%)

Healthcare / Medical Instruments & Supplies

AI Score 65 · Neutral

$11.92

-0.33%

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall e

Price chart

Seasonality

May has 4 positive and 1 negative years (last 5 years shown)

8% return in May, 11% avg return in past 3 year May month.

-4% return in 2026, 7% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-19%10%2%-4%8%-4%
2524%-18%1%-1%10%-3%-10%17%11%7%3%5%46%
24-24%-7%7%-2%9%-3%28%-5%4%-14%1%31%25%
23-6%-5%-17%-20%14%9%-16%-8%-9%-15%5%18%-49%
22-26%8%-8%-3%-6%-2%18%-2%-7%-32%-9%6%-63%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 65/100

Neutral · Strong · Strong

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$446.66M

P/E ratio

52W high

$13.99

52W low

$8.36

Volume

2,05,096

Beta

0.37

Related stocks in Healthcare

Frequently asked questions

What is AngioDynamics, Inc. share price today?
AngioDynamics, Inc. (ANGO) last traded around $11.92 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does ANGO have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ANGO. Download the app for real-time alerts.
How can I analyze AngioDynamics, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro